Renaissance Technologies - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$1,255,000
-57.9%
2,613,230
+17.3%
0.00%
-66.7%
Q1 2019$2,984,000
+8.7%
2,227,185
-8.3%
0.00%0.0%
Q4 2018$2,745,000
+13.9%
2,429,485
+178.2%
0.00%
+50.0%
Q3 2018$2,410,000
-53.2%
873,227
-44.6%
0.00%
-33.3%
Q2 2018$5,150,000
+76.2%
1,576,070
+65.5%
0.00%0.0%
Q1 2018$2,923,000
-21.7%
952,185
+60.7%
0.00%
-25.0%
Q4 2017$3,733,000
+63.6%
592,493
+77.6%
0.00%
+33.3%
Q3 2017$2,282,000
+122.9%
333,585
+132.2%
0.00%
+200.0%
Q2 2017$1,024,000
-23.0%
143,685
-0.7%
0.00%
-50.0%
Q1 2017$1,330,000
-6.9%
144,685
-59.2%
0.00%0.0%
Q4 2016$1,429,000
-48.8%
354,713
-51.3%
0.00%
-60.0%
Q3 2016$2,792,000
-17.3%
729,000
-7.1%
0.01%
-16.7%
Q2 2016$3,375,000
-25.6%
784,805
-19.9%
0.01%
-33.3%
Q1 2016$4,534,000
+14.7%
979,200
+148.5%
0.01%0.0%
Q4 2015$3,952,000
+962.4%
394,050
+1332.9%
0.01%
+800.0%
Q4 2013$372,00027,5000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2016
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders